***** TODAY’S NEWS AstraZeneca still waiting for the upside of MedImmune acquisition. Pfizer: More Lipitor, fewer heart complications - A reanalysis of research data found a high dose of popular …
Pharma Commentary
Here are some links to more in-depth articles, giving commentary about various pharma-related issues: The dwindling of pharma sales forces (particular focus on Pfizer's recent tribulations) - from …